Signaling defects in iPSC-derived fragile X premutation neurons

Jing Liu, Katarzyna A. Kościelska, Zhengyu Cao, Susan Hulsizer, Natalie Grace, Gaela Mitchell, Catherine Nacey, Jackline Githinji, Jeannine McGee, Dolores Garcia-Arocena, Randi J Hagerman, Jan Nolta, Isaac N Pessah, Paul J Hagerman

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a leading monogenic neurodegenerative disorder affecting premutation carriers of the fragile X (FMR1) gene. To investigate the underlying cellular neuropathology, we produced induced pluripotent stem cell-derived neurons from isogenic subclones of primary fibroblasts of a female premutation carrier, with each subclone bearing exclusively either the normal or the expanded (premutation) form of the FMR1 gene as the active allele. We show that neurons harboring the stably-active, expanded allele (EX-Xa) have reduced postsynaptic density protein 95 protein expression, reduced synaptic puncta density and reduced neurite length. Importantly, such neurons are also functionally abnormal, with calcium transients of higher amplitude and increased frequency than for neurons harboring the normal-active allele. Moreover, a sustained calcium elevation was found in the EX-Xa neurons after glutamate application. By excluding the individual genetic background variation, we have demonstrated neuronal phenotypes directly linked to the FMR1 premutation. Our approach represents a unique isogenic, X-chromosomal epigenetic model to aid the development of targeted therapeutics for FXTAS, and more broadly as a model for the study of common neurodevelopmental (e.g. autism) and neurodegenerative (e.g. Parkinsonism, dementias) disorders.

Original languageEnglish (US)
Article numberdds207
Pages (from-to)3795-3805
Number of pages11
JournalHuman Molecular Genetics
Volume21
Issue number17
DOIs
StatePublished - Sep 2012

Fingerprint

Neurons
Alleles
Calcium
Induced Pluripotent Stem Cells
Parkinsonian Disorders
Neurites
Autistic Disorder
Epigenomics
Neurodegenerative Diseases
Genes
Dementia
Glutamic Acid
Fibroblasts
Phenotype
Proteins
Fragile X Tremor Ataxia Syndrome
Therapeutics

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Liu, J., Kościelska, K. A., Cao, Z., Hulsizer, S., Grace, N., Mitchell, G., ... Hagerman, P. J. (2012). Signaling defects in iPSC-derived fragile X premutation neurons. Human Molecular Genetics, 21(17), 3795-3805. [dds207]. https://doi.org/10.1093/hmg/dds207

Signaling defects in iPSC-derived fragile X premutation neurons. / Liu, Jing; Kościelska, Katarzyna A.; Cao, Zhengyu; Hulsizer, Susan; Grace, Natalie; Mitchell, Gaela; Nacey, Catherine; Githinji, Jackline; McGee, Jeannine; Garcia-Arocena, Dolores; Hagerman, Randi J; Nolta, Jan; Pessah, Isaac N; Hagerman, Paul J.

In: Human Molecular Genetics, Vol. 21, No. 17, dds207, 09.2012, p. 3795-3805.

Research output: Contribution to journalArticle

Liu, J, Kościelska, KA, Cao, Z, Hulsizer, S, Grace, N, Mitchell, G, Nacey, C, Githinji, J, McGee, J, Garcia-Arocena, D, Hagerman, RJ, Nolta, J, Pessah, IN & Hagerman, PJ 2012, 'Signaling defects in iPSC-derived fragile X premutation neurons', Human Molecular Genetics, vol. 21, no. 17, dds207, pp. 3795-3805. https://doi.org/10.1093/hmg/dds207
Liu J, Kościelska KA, Cao Z, Hulsizer S, Grace N, Mitchell G et al. Signaling defects in iPSC-derived fragile X premutation neurons. Human Molecular Genetics. 2012 Sep;21(17):3795-3805. dds207. https://doi.org/10.1093/hmg/dds207
Liu, Jing ; Kościelska, Katarzyna A. ; Cao, Zhengyu ; Hulsizer, Susan ; Grace, Natalie ; Mitchell, Gaela ; Nacey, Catherine ; Githinji, Jackline ; McGee, Jeannine ; Garcia-Arocena, Dolores ; Hagerman, Randi J ; Nolta, Jan ; Pessah, Isaac N ; Hagerman, Paul J. / Signaling defects in iPSC-derived fragile X premutation neurons. In: Human Molecular Genetics. 2012 ; Vol. 21, No. 17. pp. 3795-3805.
@article{3b3c2ada95124d6c94756829d5f5fec9,
title = "Signaling defects in iPSC-derived fragile X premutation neurons",
abstract = "Fragile X-associated tremor/ataxia syndrome (FXTAS) is a leading monogenic neurodegenerative disorder affecting premutation carriers of the fragile X (FMR1) gene. To investigate the underlying cellular neuropathology, we produced induced pluripotent stem cell-derived neurons from isogenic subclones of primary fibroblasts of a female premutation carrier, with each subclone bearing exclusively either the normal or the expanded (premutation) form of the FMR1 gene as the active allele. We show that neurons harboring the stably-active, expanded allele (EX-Xa) have reduced postsynaptic density protein 95 protein expression, reduced synaptic puncta density and reduced neurite length. Importantly, such neurons are also functionally abnormal, with calcium transients of higher amplitude and increased frequency than for neurons harboring the normal-active allele. Moreover, a sustained calcium elevation was found in the EX-Xa neurons after glutamate application. By excluding the individual genetic background variation, we have demonstrated neuronal phenotypes directly linked to the FMR1 premutation. Our approach represents a unique isogenic, X-chromosomal epigenetic model to aid the development of targeted therapeutics for FXTAS, and more broadly as a model for the study of common neurodevelopmental (e.g. autism) and neurodegenerative (e.g. Parkinsonism, dementias) disorders.",
author = "Jing Liu and Kościelska, {Katarzyna A.} and Zhengyu Cao and Susan Hulsizer and Natalie Grace and Gaela Mitchell and Catherine Nacey and Jackline Githinji and Jeannine McGee and Dolores Garcia-Arocena and Hagerman, {Randi J} and Jan Nolta and Pessah, {Isaac N} and Hagerman, {Paul J}",
year = "2012",
month = "9",
doi = "10.1093/hmg/dds207",
language = "English (US)",
volume = "21",
pages = "3795--3805",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "17",

}

TY - JOUR

T1 - Signaling defects in iPSC-derived fragile X premutation neurons

AU - Liu, Jing

AU - Kościelska, Katarzyna A.

AU - Cao, Zhengyu

AU - Hulsizer, Susan

AU - Grace, Natalie

AU - Mitchell, Gaela

AU - Nacey, Catherine

AU - Githinji, Jackline

AU - McGee, Jeannine

AU - Garcia-Arocena, Dolores

AU - Hagerman, Randi J

AU - Nolta, Jan

AU - Pessah, Isaac N

AU - Hagerman, Paul J

PY - 2012/9

Y1 - 2012/9

N2 - Fragile X-associated tremor/ataxia syndrome (FXTAS) is a leading monogenic neurodegenerative disorder affecting premutation carriers of the fragile X (FMR1) gene. To investigate the underlying cellular neuropathology, we produced induced pluripotent stem cell-derived neurons from isogenic subclones of primary fibroblasts of a female premutation carrier, with each subclone bearing exclusively either the normal or the expanded (premutation) form of the FMR1 gene as the active allele. We show that neurons harboring the stably-active, expanded allele (EX-Xa) have reduced postsynaptic density protein 95 protein expression, reduced synaptic puncta density and reduced neurite length. Importantly, such neurons are also functionally abnormal, with calcium transients of higher amplitude and increased frequency than for neurons harboring the normal-active allele. Moreover, a sustained calcium elevation was found in the EX-Xa neurons after glutamate application. By excluding the individual genetic background variation, we have demonstrated neuronal phenotypes directly linked to the FMR1 premutation. Our approach represents a unique isogenic, X-chromosomal epigenetic model to aid the development of targeted therapeutics for FXTAS, and more broadly as a model for the study of common neurodevelopmental (e.g. autism) and neurodegenerative (e.g. Parkinsonism, dementias) disorders.

AB - Fragile X-associated tremor/ataxia syndrome (FXTAS) is a leading monogenic neurodegenerative disorder affecting premutation carriers of the fragile X (FMR1) gene. To investigate the underlying cellular neuropathology, we produced induced pluripotent stem cell-derived neurons from isogenic subclones of primary fibroblasts of a female premutation carrier, with each subclone bearing exclusively either the normal or the expanded (premutation) form of the FMR1 gene as the active allele. We show that neurons harboring the stably-active, expanded allele (EX-Xa) have reduced postsynaptic density protein 95 protein expression, reduced synaptic puncta density and reduced neurite length. Importantly, such neurons are also functionally abnormal, with calcium transients of higher amplitude and increased frequency than for neurons harboring the normal-active allele. Moreover, a sustained calcium elevation was found in the EX-Xa neurons after glutamate application. By excluding the individual genetic background variation, we have demonstrated neuronal phenotypes directly linked to the FMR1 premutation. Our approach represents a unique isogenic, X-chromosomal epigenetic model to aid the development of targeted therapeutics for FXTAS, and more broadly as a model for the study of common neurodevelopmental (e.g. autism) and neurodegenerative (e.g. Parkinsonism, dementias) disorders.

UR - http://www.scopus.com/inward/record.url?scp=84865064735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865064735&partnerID=8YFLogxK

U2 - 10.1093/hmg/dds207

DO - 10.1093/hmg/dds207

M3 - Article

C2 - 22641815

AN - SCOPUS:84865064735

VL - 21

SP - 3795

EP - 3805

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 17

M1 - dds207

ER -